Holen Sie sich die Stockscreener-App
0.0127
10.43%
0.0012
Schlusskurs vom Vortag:
$0.0115
Offen:
$0.011
24-Stunden-Volumen:
5,650
Relative Volume:
0.56
Marktkapitalisierung:
$N/A
Einnahmen:
$7.68M
Nettoeinkommen (Verlust:
$-42.95M
KGV:
-0.000556
EPS:
-22.8421
Netto-Cashflow:
$-36.62M
1W Leistung:
+15.45%
1M Leistung:
+15.45%
6M Leistung:
-90.24%
1J Leistung:
-95.82%
1-Tages-Spanne:
$0.011
$0.015
1-Wochen-Bereich:
$0.011
$0.015
52-Wochen-Spanne:
$0.005
$0.165
T 2 Biosystems Inc Stock (TTOO) Company Profile
Firmenname
T 2 Biosystems Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie TTOO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TTOO
T 2 Biosystems Inc
|
0.0127 | 0 | 7.68M | -42.95M | -36.62M | -22.84 |
|
TMO
Thermo Fisher Scientific Inc
|
570.16 | 216.37B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
224.70 | 161.42B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
693.18 | 55.94B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
139.19 | 39.80B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
221.68 | 38.08B | 15.90B | 1.28B | 2.21B | 7.2842 |
T 2 Biosystems Inc Stock (TTOO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-01-27 | Herabstufung | Alliance Global Partners | Buy → Neutral |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2019-11-26 | Herabstufung | Janney | Buy → Neutral |
| 2019-08-01 | Herabstufung | Alliance Global Partners | Buy → Neutral |
| 2019-07-31 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2019-07-31 | Herabstufung | Janney | Buy → Neutral |
| 2019-05-16 | Eingeleitet | Alliance Global Partners | Buy |
| 2019-03-08 | Bestätigt | H.C. Wainwright | Buy |
| 2018-06-01 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-05-30 | Bestätigt | H.C. Wainwright | Buy |
| 2018-05-29 | Bestätigt | WBB Securities | Strong Buy |
| 2018-03-29 | Bestätigt | H.C. Wainwright | Buy |
| 2018-01-29 | Eingeleitet | Goldman | Neutral |
| 2017-10-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-03-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2016-11-10 | Fortgesetzt | Leerink Partners | Mkt Perform |
| 2016-11-02 | Bestätigt | Cantor Fitzgerald | Buy |
| 2016-07-20 | Hochstufung | WBB Securities | Buy → Strong Buy |
| 2016-06-22 | Hochstufung | WBB Securities | Speculative Buy → Buy |
| 2016-04-12 | Bestätigt | Canaccord Genuity | Buy |
| 2016-02-17 | Eingeleitet | WBB Securities | Speculative Buy |
Alle ansehen
T 2 Biosystems Inc Aktie (TTOO) Neueste Nachrichten
T2 Biosystems (NASDAQ:TTOO) Shares Cross Above 50-Day Moving Average – What’s Next? - Defense World
Stocks in play: Microbix Biosystems Inc. - The Globe and Mail
T2 Biosystems Inc. (TTOO) Stock Price | Live Quotes & Charts | OTO - StocksToTrade
T2 Biosystems (NASDAQ:TTOO) Shares Cross Above 50 Day Moving Average – What’s Next? - Defense World
Tangible book value per share of T2 Biosystems, Inc. – LSE:0A57 - TradingView
Ocean Dx sepsis test matches gold standard in early study - BioWorld MedTech
TTOO Interactive Stock Chart | T2 Biosystems, Inc. Stock - Yahoo Finance
T2 Biosystems Inc. (TTOO): 2025 Product Pipeline and Strategy Analysis Report - Yahoo Finance
Why retail investors favor Rapid Micro Biosystems Inc. stock2025 Trading Volume Trends & Low Risk Entry Point Tips - nchmf.gov.vn
Rapid Micro Biosystems And 2 Promising Penny Stocks To Watch - Yahoo Finance
GBS (NYSE:GBS) versus T2 Biosystems (NASDAQ:TTOO) Head-To-Head Survey - Defense World
Contestants Turn in a Terrific Short Selling Performance - TradingView
Reviewing T2 Biosystems (NASDAQ:TTOO) & Titan Medical (NASDAQ:TMDIF) - Defense World
Revenue per share of T2 Biosystems, Inc. – OTC:TTOO - TradingView
EBIT per share of T2 Biosystems, Inc. – OTC:TTOO - TradingView
T2 Biosystems (NASDAQ:TTOO) Stock Crosses Below Two Hundred Day Moving Average – Here’s Why - Defense World
Phase 2 HER2 Clinical Trial Manufacturing Commenced, WSU Imaging Optimisation Program Underway - Investing News Network
Lyme Disease Pipeline 2025: In-Depth Clinical Trials Analysis And Emerging Therapies Report By Delveinsight Abbott, Bio-Rad Laboratories, Inc., Covance Inc.F. Hoffmann-La Roche AG, T2 Biosystems - Menafn.com
Reviewing Titan Medical (NASDAQ:TMDIF) and T2 Biosystems (NASDAQ:TTOO) - Defense World
Sepsis Diagnostics Market Poised for Remarkable Expansion by 2035, Reveals Prophecy Market Insights Study - newstrail.com
Will Retractable Technologies Inc. outperform the marketJuly 2025 Outlook & High Accuracy Trade Alerts - Newser
T2 Biosystems, Inc. (NASDAQ:TTOO) Sees Significant Drop in Short Interest - Defense World
Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Misses Revenue Estimates - MSN
Rapid Micro Biosystems Reports 15% Recurring Revenue Growth, Lands Major $45M Financing Deal - Stock Titan
Apyx Medical Strengthens Global Sales Leadership with Strategic Hires as New AYON System Launches - Stock Titan
Short Interest in T2 Biosystems, Inc. (NASDAQ:TTOO) Expands By 1,146.7% - Defense World
Targeting iron regulatory protein 2 (IRP2) to disrupt iron metabolism enhances radiosensitivity through mitochondrial dysfunction in breast cancer cells - Nature
Rapid Micro: Lake Street initiates coverage with Buy rating, PT $8. - AInvest
T2 Biosystems (NASDAQ:TTOO) versus InspireMD (NYSE:NSPR) Financial Review - Defense World
What analysts say about Rapid Micro Biosystems Inc. stockUnmatched profit potential - Autocar Professional
Head to Head Survey: Presbia (OTCMKTS:LENSF) & T2 Biosystems (NASDAQ:TTOO) - Defense World
Does Rapid Micro Biosystems Inc. stock pay reliable dividends200 Percent Profit Outlook - beatles.ru
Vivid Dx Appoints Diagnostics Veteran John Sperzel as Chief Executive Officer and Board Member - GlobeNewswire Inc.
TTOO SEC FilingsT2 Biosystems 10-K, 10-Q, 8-K Forms - Stock Titan
Upcoming Earnings Reports and Analyst Ratings Actions - AInvest
Delisting of Securities from The Nasdaq Stock Market - Yahoo Finance
Emerging Lyme Disease Diagnostics Market Opportunities - openPR.com
North American Morning Briefing: Stock Futures Down, Earnings Expectations, and Analyst Ratings Actions - AInvest
Critical Comparison: T2 Biosystems (NASDAQ:TTOO) vs. ClearPoint Neuro (NASDAQ:CLPT) - Defense World
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
T2 BIOSYSTEMS Earnings Preview: Recent $TTOO Insider Trading, Hedge Fund Activity, and More - Nasdaq
Biotech layoff tracker: 21 companies cut 1,000 jobs in Q1 2025 - The Business Journals
Rapid Micro Biosystems And 2 Other Promising Penny Stocks To Consider - simplywall.st
Microbix Biosystems Leads These 3 TSX Penny Stocks To Watch - simplywall.st
Rapid Micro Biosystems, Inc. (RPID): Among the Hot Penny Stocks to Buy Now - Yahoo Finance
T2 Biosystems initiates major layoffs, seeks asset sale - Investing.com
Medical diagnostics firm T2 Biosystems cuts ‘substantially all’ workers - The Business Journals
T2 Biosystems Reduces Workforce Amid Nasdaq Delisting Notice - TipRanks
T2 Biosystems, Inc. Balance Sheet – OTC:TTOO - TradingView
TTOO Stock Price and Chart — OTC:TTOO - TradingView
Epicore Biosystems scores $26M to expand sweat-sensing wearable technology - Mobi Health News
Finanzdaten der T 2 Biosystems Inc-Aktie (TTOO)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.49%
Kapitalisierung:
|
Volumen (24h):